Shanghai Jsure Health Technology Co., Ltd., established in 2008, is a digital patient solution provider for pharmaceutical industry. Jsure has established close relationships with 200+ sites and 20,000+ physicians and had experience in more than 350+ clinical trials projects across 40+ disease areas. Jsure helps 40 new drugs accelerate the approval of the market, and brings hope to life for 80,000+ patients.
Jsure provides integrated clinical research and innovative digital patient solutions for pharmaceutical enterprises. Jsure Health's solutions include leading patient recruitment services（TrustRecruit™）, China 's ePRO complete solutions（ePData™）, and ePRO-driven disease management solutions with digital supporting for pharmaceutical enterprises, physicians, and patients（ePConnect™）. Jsure Health helps pharmaceutical enterprises accelerate the pace of clinical trials and the approval of the market and promotes the development of the medical and health industry.
Jsure is a national high-tech enterprise with dozens of software copyrights. Jsure has passed ISO9001, ISO27001 and ISO20001 and other quality system certifications, and passed the US FDA CFR Title 21 Part 11 international third-party verification.
Jsure’s patient recruitment team covers more than 40 cities across the country. The core team has professional medical knowledge background and multinational enterprise management experience. Jsure focuses on employee development and growth with the company.
Jsure listed on the new OTC market in 2015. The stock code is 834294.